CAS 198480-56-7|Bazedoxifene hydrochloride

Introduction:Basic information about CAS 198480-56-7|Bazedoxifene hydrochloride, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Common NameBazedoxifene hydrochloride
CAS Number198480-56-7Molecular Weight507.06400
Density/Boiling Point/
Molecular FormulaC30H35ClN2O3Melting Point/
MSDS/Flash Point/

Names

Name1-[[4-[2-(azepan-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methylindol-5-ol,hydrochloride
SynonymMore Synonyms

Bazedoxifene hydrochloride BiologicalActivity

DescriptionBazedoxifene hydrochloride (TSE-424 hydrochloride) is an oral, BBB-penetrant nonsteroidal selective estrogen receptor modulator (SERM), with IC50s of 23 nM and 99 nM for ERα and ERβ, respectively. Bazedoxifene hydrochloride can be used for the research of osteoporosis. Bazedoxifene hydrochloride also acts as an inhibitor of IL-6/GP130 protein-protein interactions and can be used for the research of pancreatic cancer[1][2].
Related CatalogSignaling Pathways >>Others >>Estrogen Receptor/ERRResearch Areas >>Cancer
Target

IC50: 26 nM (ERα), 99 nM (ERβ)[1]

In VitroBazedoxifene hydrochloride is a small molecular GP130 inhibitor, which binds to GP130 D1 domain[1]. Bazedoxifene hydrochloride inhibits STAT3 phosphorylation induced by Il-6 and IL-11 in GP130/STAT3 pathway signaling[1]. Bazedoxifene hydrochloride (10 μM-20 μM; 2 hours) inhibits STAT3 Phosphorylation Induced by cytokines in human pancreatic cancer cells[2]. Bazedoxifene hydrochloride (5-20 μM; overnight) induces apoptosis in human pancreatic cancer cells[2]. Bazedoxifene hydrochloride inhibits STAT3 nuclear translocation induced by IL-6[2]. Bazedoxifene hydrochloride blocks the cells migration in pancreatic cancer cells by inhibition of GP130[2]. Western Blot Analysis[2] Cell Line: AsPC-1 cells Concentration: 10 μM, 20 μM Incubation Time: 2 hours Result: Inhibited IL-6, IL-11 or OSM (50 ng/mL) induced STAT3 phosphorylation. Apoptosis Analysis[2] Cell Line: Capan-1 cells, BxPC-3 cells, HPAF-II cells, HPAC cells Concentration: 10 μM, 20 μM (Capan-1); 5 μM, 10 μM (BxPC-3); 10 μM, 20 μM (HPAF-II); 10 μM, 15 μM (HPAC) Incubation Time: Overnight Result: Induced apoptosis.
In VivoBazedoxifene hydrochloride (5 mg/kg; i.g.; daily, for 18 days) inhibits Capan-1 tumor growth in mouse model in vivo[2]. Animal Model: 6-week-old female athymic nude mice[2] Dosage: 5 mg/kg Administration: Oral gavage, daily, for 18 days Result: Suppressed pancreatic cancer xenograft tumor growth and induced apoptosis in tumor cells.
References

[1]. Barry S Komm, et al. Bazedoxifene acetate: a selective estrogen receptor modulator with improved selectivity. Endocrinology. 2005 Sep;146(9):3999-4008.

[2]. Xiaojuan Wu, et al. Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy. Mol Cancer Ther. 2016 Nov; 15(11): 2609–2619.

Chemical & Physical Properties

Molecular FormulaC30H35ClN2O3
Molecular Weight507.06400
Exact Mass506.23400
PSA57.86000
LogP7.07090
InChIKeyCOOWZQXURKSOKE-UHFFFAOYSA-N
SMILESCc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12.Cl
Storage condition-20℃

Synonyms

Bazedoxifene HCl
CAS 81306-93-6|N-[(1,1-Dimethylethoxy)carbonyl]-3-[[(phenylmethoxy)carbonyl]amino]-D-alanine
CAS 1252867-16-5|Azepane-1,3-dicarboxylic acid 1-tert-butyl ester
Recommended......
TOP